Dr. Gonzalo Calvo has been re-elected by the Healthcare Professionals’ Working Party (HCPWP) of the European Medicines Agency (EMA) as its co-chair.
The Healthcare Professionals' Working Party (HCPWP) of the European Medicines Agency (EMA) has re-elected Dr. Gonzalo Calvo as its co-chair.
Calvo, a physician and consultant in clinical pharmacology from Barcelona, Spain, has extensive experience in medicines regulation, including nearly 10 years as a member of EMA’s Committee for Medicinal Products for Human Use (CHMP).
“My aim is to consolidate the work initiated and open new paths to strengthen the role and impact of healthcare professionals in regulatory activities, securing fast and safe access to new medicines,” said Calvo. “Close collaboration with the patients and consumers’ working group has been instrumental for the progress of HCPWP work. I do not see any other way forward than enhancing our interaction with patients and consumers.”
Together with Isabelle Moulon, Head of the Public Engagement Department at EMA, he will co-chair HCPWP for the next three years.
No decision was reached, however, on the new co-chair of the Patients' and Consumers' Working Party (PCWP).
The main role of the PCWP and the HCPWP is to provide recommendations to EMA and its scientific committees on all matters of interest to either patients and consumers or healthcare professionals in relation to medicines, as well as to monitor interactions between the agency and patients, consumers and healthcare professionals.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.